Idexx Laboratories
IDXX
542 hedge funds and large institutions have $12.2B invested in Idexx Laboratories in 2017 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 161 increasing their positions, 223 reducing their positions, and 49 closing their positions.
57% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 49
33% more capital invested
Capital invested by funds: $9.18B → $12.2B (+$3.05B)
15% more funds holding in top 10
Funds holding in top 10: 20 → 23 (+3)
4% more funds holding
Funds holding: 523 → 542 (+19)
2.78% more ownership
Funds ownership: 87.21% → 89.99% (+2.8%)
28% less repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 223
36% less call options, than puts
Call options by funds: $11.4M | Put options by funds: $17.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$843M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$240M |
| 3 |
State Street
Boston,
Massachusetts
|
+$150M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$145M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$127M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
-$157M |
| 2 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$98.2M |
| 3 |
BAMCO Inc
New York
|
-$85.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$54.5M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$44.5M |
IDXX Hedge Fund Activity: Q1 2017 in Review
542 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2017, worth a combined $12.2B — up 33% from $9.18B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new IDXX positions and 49 closed out — a net gain of 28 holders — while 161 added to existing stakes and 223 trimmed.
The largest buyer was BlackRock, adding an estimated $843M. The largest seller was Select Equity Group, cutting an estimated $157M.
- 542 institutional investors held Idexx Laboratories (IDXX) as of Q1 2017, up from 523 in Q4 2016.
- Funds reported $12.2B of Idexx Laboratories stock for Q1 2017, up 33% quarter-over-quarter.
- 77 funds opened new Idexx Laboratories positions in Q1 2017 and 49 closed out, a net change of +28 holders.
- The largest Idexx Laboratories buyer in Q1 2017 was BlackRock, an estimated $843M added.
- The largest Idexx Laboratories seller in Q1 2017 was Select Equity Group, an estimated $157M sold.
Based on aggregated 13F filings for Q1 2017.